Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rxsight Inc (NQ: RXST )

60.65 -1.61 (-2.59%)
Official Closing Price Updated: 4:15 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 329,785
Open 62.34
Bid (Size) 60.19 (1)
Ask (Size) 61.13 (1)
Prev. Close 62.26
Today's Range 59.56 - 62.36
52wk Range 20.66 - 66.54
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From RxSight, Inc.
Via GlobeNewswire
Why RxSight (RXST) Shares Are Falling
RxSight shares are trading lower by 5.6% during Thursday's session. The company announced pricing of its $100 million proposed public offering of common stock. 
Via Benzinga

Performance

YTD
+65.48%
+65.48%
1 Month
+14.80%
+14.80%
3 Month
+10.37%
+10.37%
6 Month
+120.31%
+120.31%
1 Year
+147.35%
+147.35%

More News

Read More
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
From RxSight, Inc.
Via GlobeNewswire
What 10 Analyst Ratings Have To Say About RxSight
Via Benzinga
Assessing RxSight: Insights From 8 Financial Analysts
Via Benzinga
Forecasting The Future: 9 Analyst Projections For RxSight
Via Benzinga
RxSight, Inc. Announces Proposed Public Offering of Common Stock
From RxSight, Inc.
Via GlobeNewswire
RXST Stock Earnings: RxSight Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
RxSight, Inc. Reports First Quarter 2024 Financial Results
From RxSight, Inc.
Via GlobeNewswire
Recap: RxSight Q4 Earnings
Via Benzinga
RxSight's Earnings Outlook
Via Benzinga
Stifel Maintains Buy Rating for RxSight: Here's What You Need To Know
Via Benzinga
RxSight, Inc. to Present at the Bank of America Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
From RxSight, Inc.
Via GlobeNewswire
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
From RxSight, Inc.
Via GlobeNewswire
The Analyst Landscape: 8 Takes On RxSight
Via Benzinga
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
Chart Of The Day: RxSight - Cashing In On Cataracts
Via Talk Markets
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
From RxSight, Inc.
Via GlobeNewswire
Earnings Scheduled For February 28, 2024
Via Benzinga
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
From RxSight, Inc.
Via GlobeNewswire
Insiders are selling these hot stocks on track for higher prices
Via MarketBeat
Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.